This Week in Health News: 12 Stories You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including new endowments for innovative research, women's health advocacy, and a breakthrough in neuromodulation therapy.
NEW YORK, Oct. 11, 2024 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.
The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.
Unlocking the Connection: New White Paper from MyFitnessPal Explores the Impact of Nutrition on MoodMyFitnessPal – in conjunction with Dr. Jenny L. Taitz, Psy.D. – is publishing a new white paper titled the Food + Mood which demonstrates a link between dietary habits and mood. The average American consumes nearly double the American Heart Association's recommended daily limit of added sugar, which correlates to a higher prevalence of depression.
Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly DoseCredelio Quattro is the newest addition to the Credelio® (lotilaner) franchise and the first FDA-approved parasiticide product with four active ingredients. "Zoonotic disease is more common than many might think. One of our own Elanco veterinarians recently found echinococcus tapeworm lurking in her back yard," said Dr. David Gosche.
Education industry professionals join at 3rd annual Healthy Building Summit to collaborate on 'Spaces of Connection'Sessions at this year's summit dove into topics like how the brain responds to environmental influences, intentional design as a form of advocacy, the culture of space, and how biophilic design enhances spaces of connection and belonging. The summit also welcomed a high school student's perspective on priorities of well-being and engagement.
California Takes Bold Step to Revolutionize Youth Sports with 25x25 Coaches ChallengeThe California Governor's Advisory Council on Physical Fitness and Mental Well-being is teaming up with the Susan Crown Exchange's Million Coaches Challenge (MCC) to launch 25x25: The California Coaches Challenge. This initiative aims to train 25,000 coaches in positive youth coaching across California by the end of 2025.
New study by Premise Health finds advanced primary care saves employers and unions 30% on total healthcare costs for attributed membersIndustry watchers are projecting the biggest jump in healthcare costs in a decade for 2025, with Business Group on Health's 2025 Employer Health Care Strategy Survey reporting that employers are expecting nearly 8% increases.
Hyundai Hope On Wheels Awards Inaugural Endowed $3 Million Grant to Support Generations of ResearchersHyundai Hope On Wheels established the Hyundai Hope On Wheels Endowed Chair in Pediatric Oncology, with a $3 million commitment which will ensure that future generations of researchers continue into perpetuity at leading medical institutions.
Montefiore AIDS Center Awarded $1 Million to Curb Disproportionate Impact of HIV on Women of Color in the BronxFunding will support engagement of approximately 200 women of color in the Bronx, ages 16 and up, by offering HIV testing, sexual and reproductive health workshops, mental health and supportive services as well as employment readiness opportunities, including vocational counseling, interview preparation, clothing vouchers and referrals to childcare resources.
Avive Solutions Selected as Preferred Provider for NFL's Smart Heart Sports Coalition "AEDs for Youth" ProgramAs part of the AEDs for Youth program, Avive's state-of-the-art Avive Connect AED and exclusive, discounted product bundles for schools and athletics will empower educators, school staff, students, coaches and athletes to respond swiftly to Sudden Cardiac Arrest emergencies.
Serving More Than Looks: Maybelline New York Announces Naomi Osaka as The Brand's First Brave Together AmbassadorAs the brand's first-ever Brave Together global ambassador, Osaka will lend her voice and first-hand connection to the mental health program, joining Maybelline on its mission to make one-to-one support for anxiety and depression accessible to all.
Olivia Rodrigo to Honor Her Filipino Heritage by Partnering with Jhpiego to Support Women's Health and Empowerment During Her First-Ever Show in the PhilippinesRodrigo's support for Jhpiego's work in the Philippines is part of her larger commitment to giving back, especially to women and girls. Jhpiego, a Johns Hopkins University affiliate, has long worked to improve the health and lives of Filipino women and girls, particularly in underserved and conflict-affected regions.
Neurolief Presents Groundbreaking Study Results of its Proliv™Rx Brain Neuromodulation Therapy for Treating Major Depression at the 7th Annual Neuropsychiatric Drug SummitThe summit, which brought together executives from major pharmaceutical companies and key stakeholders in psychiatric drug development, offered a forum for Neurolief to demonstrate the transformative potential of Proliv™Rx. Dr. Carpenter's presentation generated substantial interest and reflected the pharma industry's growing focus on "beyond the pill" solutions for mental health treatment.
Healthline Survey Reveals Critical Gaps in Preventive Care, Majority of Respondents Use Social Media for Health TacticsLess than half (42%) of Americans had an annual physical exam in the past year, with even fewer visiting the dentist for a routine exam and cleaning (37%). The findings also reveal surprising trends on where US adults are getting their health information.
Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.
World Mental Health Day
October 10 was World Mental Health Day, and brands, individuals, and organizations around the world spent the week bringing awareness to this important health issue. Millions worldwide experience some form of challenge with their mental health, and in this rapidly changing world, it's more important than ever to take care of ourselves.
Below are just a few stories issued this week regarding mental health and well-being:
National Poll on Perceptions of Mental Health and Suicide Prevention Reveals Most U.S. Adults Believe Suicide is Preventable
Workplace Psychologist John O'Brien: Five Steps to Overcome Rudeness at Work
New Data: College Students Want to Push for Mental Health Reform, But Few Know the Policy Issues
Helping Journalists Stay Up to Date on Industry News
These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.
Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:
Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more.
Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story.
Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles.
Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more.
About PR Newswire
PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.
For questions, contact the team at media.relations@cision.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/this-week-in-health-news-12-stories-you-need-to-see-302273494.html
SOURCE PR Newswire
Hashtags
- HealthScience#American,CredelioQuattro™,Quattro,Credelio®,FDA-approved,3rd,HealthyBuildingSummit,25x25CoachesChallengeThe,MillionCoachesChallenge,25x25:TheCaliforniaCoachesChallenge,EmployerHealthCareStrategySurvey,HyundaiHopeOn,JennyL.Taitz,DavidGosche,PRNewswire,Elanco,PRNewswire,MyFitnessPal,AmericanHeartAssociation,FDA,CaliforniaGovernor'sAdvisoryCouncilonPhysicalFitnessandMentalWell-being,SusanCrownExchange,MCC,PremiseHealth,BusinessGrouponHealth
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
30 minutes ago
- Associated Press
Felycin®-CA1 (sirolimus delayed-release tablets) Redefines Feline Cardiac Care
First-in-class oral management option for hypertrophic cardiomyopathy earns FDA conditional approval, changing the landscape of feline medicine PENSACOLA, Fla., June 12, 2025 /PRNewswire/ -- Pegasus Laboratories/PRN Pharmacal has announced the addition of a new FDA conditionally approved drug, Felycin®-CA1 (sirolimus delayed-release tablets), to their portfolio. This first-in-class therapy is designed to manage ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM), representing a major milestone in feline medicine and offering new hope to owners of cats living with this progressive and often fatal disease. HCM is a heart condition which causes the muscular walls of a cat's heart to become abnormally thick, reducing the heart's ability to pump blood efficiently. This can lead to heart failure and other complications, including sudden death. Many cats with HCM remain subclinical for years, while others may develop symptoms of congestive heart failure. While the exact cause of the disease is not fully understood, HCM is more common in certain breeds, including British Shorthair, Chartreux, Maine Coon, Persian, Ragdoll, and Sphynx cats. Researchers have also identified mutations in various cardiac genes causing HCM in several of these breeds. 'Felycin-CA1 signals a turning point in feline medicine by providing veterinarians a much-needed option to help slow the progression of HCM beyond just managing the disease,' said Dr. Heather Davis, DVM, PhD, DACVS-LA, Director of Clinical Affairs and Veterinary Services at Pegasus Laboratories. 'It is a major step forward for cats and the people who care for them. For the first time, we're changing the conversation around what's possible in feline heart care.' FDA conditional approval of Felycin®-CA1 follows results from a multi-center study demonstrating its ability to improve key cardiac outcomes, while also proving its ease of use in everyday veterinary practices. 'Veterinarians have long-needed options beyond palliative care when it comes to feline HCM,' said Dr. Joshua Stern, DVM, PhD, DACVIM. 'With Felycin-CA1, we can offer a therapy that has been shown in our initial clinical trial to stop progressive heart muscle thickening, slowing disease progression. We believe this management option marks the beginning of a new chapter where innovation in feline therapeutics becomes the rule, not the exception.' Felycin®-CA1 is slated to be available beginning August 2025, in 0.4 mg, 1.2 mg, and 2.4 mg tablet strengths by prescription from a licensed veterinarian. Cats should be screened for pre-existing liver disease before starting the medication, and it should not be used in cats with pre-existing liver disease or diabetes mellitus. About Pegasus Laboratories Pegasus Laboratories, Inc., based in Pensacola Florida, is a pharmaceutical development and manufacturing organization focused on innovative products to treat chronic conditions in cats, dogs, and horses. Our products go to market under the PRN® Pharmacal brand. We also serve as a contract manufacturer for the Animal Health industry. We were founded in 1985 and acquired by PBI-Gordon Companies, Inc. in 1999. View original content to download multimedia: SOURCE Pegasus/PRN Pharmacal
Associated Press
30 minutes ago
- Associated Press
WebMD Health Services Report: Employee Mental Health Continues to Dip--and Many Feel Employer Support Falls Short
New Survey Finds Only 1 in 4 Employees Strongly Agree Their Employer Cares About Their Well-Being PORTLAND, Ore., June 12, 2025 /PRNewswire/ -- Employee well-being and mental health have declined over the past year, and fewer employees feel that their organizations' care about their well-being, according to a new study from the WebMD Health Services Center for Research. Workplace Well-Being in 2025, released today, is based on the 2025 Workplace and Employee Survey—an initiative designed to better understand the dynamics surrounding employees and their perceptions of well-being, work, and the workplace. Click here to view the full Workplace Well-Being in 2025 report. Mental Health Struggles Persist as Employees Feel Less Supported at Work There was a 14-point drop from 2024 to 2025 in the percentage of employees reporting 'Excellent' mental health. Female employees rated their mental health lower than male employees, with the largest gaps seen among Gen Z and Millennial workers—differences of 21% and 19%, respectively. These disparities may reflect life transitions more common in these age groups, including early career pressures and caregiving responsibilities. By identifying these vulnerable populations, employers have an opportunity to tailor mental health interventions to those most in need. 'The decline in employee mental health over the past year is a clear signal that organizations must prioritize well-being and support systems more than ever,' said Erin Seaverson, Senior Director of the Center for Research at WebMD Health Services. 'As the workplace continues to evolve, fostering an environment that values mental health is essential to not only support employees but also to drive organizational success.' Work and Life Pressures Both Impact Mental Health Employees with better mental health reported higher levels of engagement, a stronger sense of belonging, and more positive perceptions of organizational care. Additionally, mental health was found to be positively correlated with life satisfaction and negatively correlated with life stress. These findings highlight the need to view mental health as interconnected with both work and personal life. Employee Perception of Organizational Support Remains Low Only 25% of employees strongly agree that their organization cares about their well-being. The study found that this perception has declined by 5% from 2024 to 2025, signaling increased uncertainty or dissatisfaction with workplace well-being support. Perceptions of care vary across industries, work arrangements, and roles, with senior leaders being 28 percentage points more likely than individual contributors to agree that their organization cares about their well-being. This disconnect is crucial to address, as leaders play a key role in shaping organizational culture. Identifying and addressing these gaps will help create a more consistent experience for all employees. The Impact of Organizational Care Extends Beyond the Workplace Employees who feel cared for are more likely to thrive—both professionally and personally. Those with a strong perception of organizational care report 56% higher engagement, 37% lower burnout, and greater retention compared to those who feel less supported. Outside of work, they also experience higher overall well-being and life satisfaction. 'Investing time and energy into building a strong culture of care is a smart strategic decision for any organization,' said Seaverson. 'The impact of organizational care is profound, both within the workplace and beyond. Care truly matters.' Survey Methodology The online survey, conducted by the WebMD Health Services Center for Research, gathered responses from more than 4,000 full-time employees based in the United States. It gathered data on five core concepts related to employee experience, including well-being and mental health, organizational care, employee engagement, burnout, and quality of life. Additional data gathered included individual demographics and job-related details, along with organizational factors, including industry sector, organization size, work arrangement, employee role, and tenure. The margin of error for the survey was +/- 2%. About WebMD Health Services WebMD Health Services, a part of WebMD Health Corp., has over 25 years of experience driving positive behavior changes. Consumers trust WebMD for reliable, accurate, and clear answers to their most pressing health-related questions. At WebMD Health Services, we tap into these valuable consumer insights to design and implement successful, engaging solutions to help individuals meet their wellbeing needs. We understand that there are numerous paths to reach wellbeing goals. Our expertise, combined with a variety of third-party partner integrations, enables us to deliver unique and personalized experiences across a wide range of industries. See how we support these diverse populations at About WebMD Health Corp. WebMD Health Corp., an Internet Brands company, is at the heart of the digital health revolution that is transforming the healthcare experience for consumers, patients, healthcare professionals, employers, health plans and health systems. Through public and private online portals, mobile platforms, and health-focused publications, WebMD delivers leading-edge content and digital services that enable and improve decision-making, support and motivate health actions, streamline and simplify the healthcare journey, and improve patient care. The WebMD Health Network includes WebMD Health, Medscape, WebMD Ignite (encompassing Krames, The Wellness Network and Mercury Healthcare), Jobson Healthcare Information, MediQuality, Frontline, Vitals Consumer Services, Aptus Health, PulsePoint, The Wellness Network, SanovaWorks, MNG Health, MedicineNet, eMedicineHealth, RxList, OnHealth, Medscape Education, and other owned WebMD sites. WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries. View original content to download multimedia: SOURCE WebMD Health Services
CNN
38 minutes ago
- CNN
Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that's the No. 1 cause of hospitalization in infants. The US Food and Drug Administration has approved a new monoclonal antibody to help prevent infection, according to an announcement late Monday from drugmaker Merck. Enflonsia is designed to be given in a single 105-milligram shot to protect newborns and infants from mild, moderate or severe RSV through all five months of their first virus season, which typically starts in the fall and goes through the next spring. Study materials that Merck submitted to the FDA for its approval showed that the antibody had a similar safety profile as a placebo. The most common adverse reactions from Enflonsia were mild and included injection-site swelling and a rash in a small number of infants. In a mid- to late-stage trial, Enflonsia reduced RSV-associated hospitalizations in infants more than 84% compared with a placebo. RSV can sometimes turn into serious lower respiratory infections like pneumonia, but the shot also reduced lower respiratory infections that needed medical attention by more than 60% compared with a placebo. 'Enflonsia provides an important new preventive option to help protect healthy and at-risk infants born during or entering their first RSV season,' Dr. Dean Y. Li, president of Merck Research Laboratories, said in a news release. 'We are committed to ensuring availability of Enflonsia in the US before the start of the upcoming RSV season to help reduce the significant burden of this widespread seasonal infection on families and health care systems.' Merck says it hopes Enflonsia will be available before the start of the 2025-26 respiratory virus season. First, it needs to be recommended by the US Centers for Disease Control and Prevention, and that means going in front of the agency's Advisory Committee on Immunization Practices. It's on the agenda for the panel's meeting this month, but US Health and Human Services Secretary Robert F. Kennedy removed all the members of that committee Monday. He says he will appoint new ones, but it's unclear how long that process will take. Doctors say another tool to prevent RSV cannot come soon enough. RSV is ubiquitous, one of the most common causes of childhood illness. Most kids will catch this highly contagious respiratory virus at some point before they turn 2, according to the CDC. For many healthy adults and older kids, RSV causes a mild illness like a cold. Typically, symptoms can be managed at home, and they often go away on their own. But for infants and the elderly, it can be a different story. Very young children's immune systems are just starting to learn how to fight infections, and infants have tiny airways. RSV inflames those airways, making it difficult to breathe, and can turn into a serious lower respiratory illness like bronchiolitis or pneumonia. Some of these RSV infections can be deadly. Two to three percent of infants under 6 months are hospitalized with RSV in the US every year, according to the CDC. Among children younger than 5, about 58,000 to 80,000 are hospitalized due to RSV. There's no specific medicine to treat RSV. Doctors can give an infant supportive care and oxygen, and then they essentially wait until their oxygen levels get back to normal, said Dr. Amy Edwards, director of pediatric infection control at UH Rainbow Babies and Children's Hospital in Cleveland. 'I hate RSV,' said Edwards, who was not connected with the Merck trial. 'Just to watch them struggle to breathe, and then they get scared, and then they cry, which of course makes the breathing worse, and their little lips turn blue. It's just so hard to watch.' Enflonsia joins a handful of other tools recently made available to protect babies from, although the FDA put RSV vaccine trials involving infants and young children ages 2 to 5 on hold last year after some developed severe illness. To prevent RSV in infants, the CDC currently recommends an RSV antibody made by Sanofi and AstraZeneca, called Beyfortus, which was approved in 2023. It was in short supply during that year's RSV season, although Edwards said supply started to catch up with demand in her health care system last season, and the company pledged to produce more. The other option to protect an infant is a vaccine that a person can get during pregnancy. Together, Beyfortus and the vaccine have made a difference. A CDC study published in March found that RSV-associated hospitalization rates among infants up to 7 months during 2024-25 season were lower than in seasons when those things weren't available. Edwards just hopes people will get protection for their infants. 'Every RSV season fills us to the gills,' she said. 'This should theoretically empty us out, if we have good uptake.' Correction: A previous version of this story incorrectly described the newly approved monoclonal antibody as a therapy.
